 | Up a level |
Jump to: 2018
Number of items: 1.
2018
Chekerov, Radoslav, Hilpert, Felix, Mahner, Sven, El-Balat, Ahmed, Harter, Philipp, De Gregorio, Nikolaus, Fridrich, Claudius, Markmann, Susanne, Potenberg, Jochem, Lorenz, Ralf, Oskay-Oezcelik, Guelten, Schmidt, Marcus 
ORCID: 0000-0003-1365-2414, Krabisch, Petra, Lueck, Hans-Joachim, Richter, Rolf, Braicu, Elena Ioana, du Bois, Andreas and Sehouli, Jalid
(2018).
Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol., 19 (9).
S. 1247 - 1259.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-5488